IMNM
Immunome, Inc.
Stock
$20.90+0.01 (+0.05%)Close Oct 2, 2026
- Net income, 2025
- −$212M
Net income
Net income by fiscal year
| Period | Net income | YoY |
|---|---|---|
| 2025 | −$212M | — |
| 2024 | −$293M | — |
| 2023 | −$107M | — |
| 2022 | −$37M | — |
| 2021 | −$25M | — |
| 2020 | −$18M | — |
| 2019 | −$10M | — |
Immunome, Inc.
$20.90+0.01 (+0.05%)Close Oct 2, 2026
| Period | Net income | YoY |
|---|---|---|
| 2025 | −$212M | — |
| 2024 | −$293M | — |
| 2023 | −$107M | — |
| 2022 | −$37M | — |
| 2021 | −$25M | — |
| 2020 | −$18M | — |
| 2019 | −$10M | — |